Provider Letters


Provider communication becomes expeditious, electronic and eco-friendly

The Oklahoma Health Care Authority (OHCA) is pleased to announce its new “green” provider notification process. In going “green,” OHCA will offer providers the option of three sources of communication instead of the paper letter process. These options are:

  1. E-Mail Notification. Provider letters will be sent directly to the provider’s e-mail address.
  2. Web Alerts. A website banner on the OHCA secure site will notify providers of newly posted letters and include a link to the letters.

Providers: Please verify or update your contact information by logging in to the OHCA secure site and following these instructions:

  • Select “update provider file."
  • Verify your information; make corrections or changes as allowed.
  • Click the “submit” button.
 Search by Letter Number or Subject

Letter NumberSubjectDate Added to Web Site
2018-01 Prior Authorization of Medications to Treat Leukemia1/12/2018
2017-37 Yearly Compliance with the Deficit Reduction Act of 200511/28/2017
2017-36 Immunization Vaccine Recommendations for Pregnant Women12/18/2017
2017-35 Interqual Prior Authorization Implementation Knee and Hip Arthroplasty11/17/2017
2017-34 Prior Authorization for Vimizim (Elosulfase Alfa) and Fabrazyme (Agalsidase Beta)11/6/2017
2017-33 OHCA Program Updates11/6/2017
2017-32 Ventricular Assist Device Implantation - Effective December 1, 201710/19/2017
2017-31 Non Billable Speech Therapy Services - Effective October 15, 201710/5/2017
2017-30 Prior Authorization for Cystic Fibrosis CPT Code – Effective October 1, 20179/18/2017
2017-29 Pharmacy Revisions for Optional Non-Prescription Products and Compounded Prescriptions9/18/2017
2017-28 Prior Authorization of Medications Used to Treat Lung Cancer8/31/2017
2017-27 Prior Authorization for Lumizyme, Elaprase, Aralast, Glassia, Prolastin-C, and Zemaira8/15/2017
2017-26 Important Changes to Signature Requirements - Effective September 1, 20177/31/2017
2017-25 Revised Guidance for Face to Face Requirements for Home Health Services7/31/2017
2017-24 Molecular Pathology Prior Authorization – Effective September 1, 20177/31/2017
2017-23 Member Identification Cards - Effective November 1, 20179/7/2017
2017-22 TEFRA Updates8/2/2017
2017-21 ITU and FQHC Policy Updates8/2/2017
2017-20 ADvantage Waiver Services Policy Changes – Effective September 1, 20178/2/2017
2017-19 Developmental Disabilities Services Policy Changes8/2/2017